Post-genomic platform for development of oligonucleotide vaccines against RNA viruses: diamond cuts diamond.

Oberemok, V V; Andreeva, O A; Laikova, K V; Novikov, I A; Kubyshkin, A V

Oberemok, V V; Andreeva, O A; Laikova, K V; Novikov, I A; Kubyshkin, A V.

Afiliación

Oberemok VV; Department of Molecular Genetics and Biotechnologies, V.I. Vernadsky Crimean Federal University, Simferopol, Crimea. genepcr@mail.ru.
Andreeva OA; Engineering Center 'Genetic and Cell Biotechnologies', V.I. Vernadsky Crimean Federal University, Simferopol, Crimea. genepcr@mail.ru.
Laikova KV; Department of Molecular Genetics and Biotechnologies, V.I. Vernadsky Crimean Federal University, Simferopol, Crimea.
Novikov IA; Engineering Center 'Genetic and Cell Biotechnologies', V.I. Vernadsky Crimean Federal University, Simferopol, Crimea.
Kubyshkin AV; Biochemistry Department, V.I. Vernadsky Crimean Federal University, Simferopol, Crimea.

Inflamm Res ; 71(7-8): 729-739, 2022 Aug.

Article en En | MEDLINE | ID: mdl-35523969

Asunto(s)

Infecciones por Coronavirus; Ácidos Nucleicos; Virus ARN; Vacunas Virales; Anticuerpos Antivirales; Diamante; Genómica; Humanos; Oligonucleótidos

Palabras clave

Immunity; La-S-so; Oligonucleotide vaccine; Pandemic; Post-genomic platform; RNA viruses; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virus ARN / Vacunas Virales / Ácidos Nucleicos / Infecciones por Coronavirus Límite: Humans Idioma: En Revista: Inflamm Res Asunto de la revista: ALERGIA E IMUNOLOGIA / PATOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google